Search Results - "Cohen, Gilad N."

A finite element method for modeling diffusion of alpha‐emitting particles in tissue by Zhang, Irene P., Cohen, Gilad N., Damato, Antonio L.

“…Background Diffusing alpha‐emitters Radiation Therapy (“DaRT”) is a promising new modality for the treatment of solid tumors. Interstitial sources containing…”
Get full text

Dose to the Bladder Neck Is the Most Important Predictor for Acute and Late Toxicity After Low-Dose-Rate Prostate Brachytherapy: Implications for Establishing New Dose Constraints for Treatment Planning by Hathout, Lara, MD, Folkert, Michael R., MD, Kollmeier, Marisa A., MD, Yamada, Yoshiya, MD, Cohen, Gil'ad N., MS, Zelefsky, Michael J., MD

“…Purpose To identify an anatomic structure predictive for acute (AUT) and late (LUT) urinary toxicity in patients with prostate cancer treated with…”
Get full text

Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases by Imber, Brandon S., Young, Robert J., Beal, Kathryn, Reiner, Anne S., Giantini-Larsen, Alexandra M., Krebs, Simone, Yang, Jonathan T., Aramburu-Nunez, David, Cohen, Gil’ad N., Brennan, Cameron, Tabar, Viviane, Moss, Nelson S.

“…Background Salvage of recurrent previously irradiated brain metastases (rBrM) is a significant challenge. Resection without adjuvant re-irradiation is…”
Get full text

The American Brachytherapy Society consensus statement on intraoperative radiation therapy by Tom, Martin C., Joshi, Nikhil, Vicini, Frank, Chang, Albert J., Hong, Theodore S., Showalter, Timothy N., Chao, Samuel T., Wolden, Suzanne, Wu, Abraham J., Martin, Douglas, Husain, Zain, Badiyan, Shahed N., Kolar, Matthew, Sherertz, Tracy, Mourtada, Firas, Cohen, Gilad N., Shah, Chirag

“…Although radiation therapy has traditionally been delivered with external beam or brachytherapy, intraoperative radiation therapy (IORT) represents an…”
Get full text

AAPM Task Group 334: A guidance document to using radiotherapy immobilization devices and accessories in an MR environment by Hobson, Maritza A., Hu, Yanle, Caldwell, Barrett, Cohen, Gil'ad N., Glide‐Hurst, Carri, Huang, Long, Jackson, Paul D., Jang, Sunyoung, Langner, Ulrich, Lee, Hannah J., Levesque, Ives R., Narayanan, Sreeram, Park, Justin C., Steffen, John, Wu, Q. Jackie, Zhou, Yong

“…Use of magnetic resonance (MR) imaging in radiation therapy has increased substantially in recent years as more radiotherapy centers are having MR simulators…”
Get full text

American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy by Yamada, Yoshiya, Rogers, Leland, Demanes, D. Jeffrey, Morton, Gerard, Prestidge, Bradley R, Pouliot, Jean, Cohen, Gil'ad N, Zaider, Marco, Ghilezan, Mihai, Hsu, I-Chow

“…Abstract Purpose A well-established body of literature supports the use of high-dose-rate (HDR) brachytherapy as definitive treatment for localized prostate…”
Get full text

Feasibility and Safety of Diffusing Alpha-Emitter Radiation Therapy for Recurrent or Unresectable Skin Cancers by D'Andrea, Mark A, VanderWalde, Noam A, Ballo, Matthew T, Patra, Pradeep, Cohen, Gil'ad N, Damato, Antonio L, Barker, Christopher A

“…Patients with recurrent or unresectable skin cancers have limited treatment options. Diffusing alpha-emitter radiation therapy (DaRT), a novel solid tumor…”
Get full text

A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy by Yamada, Yoshiya, Kollmeier, Marisa A, Pei, Xin, Kan, Chu Cheng, Cohen, Gil'ad N, Donat, Sherri M, Cox, Brett W, Zelefsky, Michael J

“…Abstract Purpose We report the toxicity and biochemical tumor control outcome of a prospective Phase II study using high-dose-rate brachytherapy (HDR) alone as…”
Get full text

Qualitative Evaluation of Fiducial Markers for Radiotherapy Imaging by Chan, Maria F., Cohen, Gil’ad N., Deasy, Joseph O.

“…Purpose: To evaluate visibility, artifacts, and distortions of various commercial markers in magnetic resonance imaging (MRI), computer tomography (CT), and…”
Get full text

Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103 by Taggar, Amandeep S., Charas, Tomer, Cohen, Gil'ad N., Boonyawan, Keeratikarn, Kollmeier, Marisa, McBride, Sean, Mathur, Nitin, Damato, Antonio L., Zelefsky, Michael J.

“…Rates of rectal toxicity after low-dose-rate (LDR) brachytherapy for prostate cancer are dependent on rectal dose, which is associated with rectal distance…”
Get full text

Extended Follow-Up Outcomes from Pooled Prospective Studies Evaluating Efficacy of Interstitial Alpha Radionuclide Treatment for Skin and Head and Neck Cancers by Popovtzer, Aron, Mizrachi, Aviram, D'Andrea, Mark A, VanderWalde, Noam A, Kurman, Noga, Rosenfeld, Eli, Ben-Hur, Ran, Bellia, Salvatore Roberto, Feliciani, Giacomo, Silvern, David, Sarnelli, Anna, Ballo, Matthew T, Patra, Pradeep, Cohen, Gil'ad N, Damato, Antonio L, Shkedy, Yotam, Den, Robert B, Barker, Christopher A, Charas, Tomer, Hirshoren, Nir

“…The initial favorable efficacy and safety profile for Alpha DaRT have been demonstrated (NCT04377360); however, the longer-term safety and durability of the…”
Get full text

Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases by Imber, Brandon S., Young, Robert J., Beal, Kathryn, Reiner, Anne S., Giantini-Larsen, Alexandra M., Krebs, Simone, Yang, Jonathan T., Aramburu-Nunez, David, Cohen, Gil’ad N., Brennan, Cameron, Tabar, Viviane, Moss, Nelson S.

Get full text

Quantifying clinical severity of physics errors in high-dose rate prostate brachytherapy using simulations by Nunez, David Aramburu, Trager, Michael, Beaudry, Joel, Cohen, Gilad N., Dauer, Lawrence T., Gorovets, Daniel, Hassan Rezaeian, Nima, Kollmeier, Marisa A., Leong, Brian, McCann, Patrick, Williamson, Matthew, Zelefsky, Michael J., Damato, Antonio L.

“…To quantitatively evaluate through automated simulations the clinical significance of potential high-dose rate (HDR) prostate brachytherapy (HDRPB) physics…”
Get full text

Hip-related toxicity after prostate radiotherapy: Treatment related or coincidental? by Zelefsky, Michael J, Kollmeier, Marisa A, Gorshein, Elan, Pei, Xin, Torres, Marina, McBride, Sean, Happersett, Laura, Cohen, Gil’ad N, Yamada, Yoshiya

“…Abstract Background and purpose To evaluate the incidence and predictors of hip toxicity postradiotherapy for localized prostate cancer. Methods and materials…”
Get full text

Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer by Zelefsky, Michael J., M.D, Yamada, Yoshiya, M.D, Cohen, Gil’ad N., M.S, Shippy, Alison, B.A, Chan, Heather, B.A, Fridman, David, Zaider, Marco, Ph.D

“…Purpose: To report the 5-year tumor control and toxicity outcomes for patients with localized prostate treated with I-125 permanent implantation using an…”
Get full text

Protocol for the measurement of the absorbed dose rate to water for a planar 32P beta emitting brachytherapy source: A multi-institutional validation by Mulet, Liana, Barreto, Izabella, Cohen, Gil'ad N., Damato, Antonio L., Mauceri, Thomas, Pursley, Jennifer, Deufel, Christopher L.

“…This is a multi-institutional report on inter-observer and inter-instrument variation in the calibration of the absorbed dose rate for a planar 32P beta…”
Get full text

Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity by Marr, Brian P, Abramson, David H, Cohen, Gil'ad N, Williamson, Matthew J, McCormick, Beryl, Barker, Christopher A

“…Adjunct treatments for conjunctival malignancies are needed when standard therapy provides limited benefits or fails. To describe the results of patients with…”
Get more information

Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience by Zelefsky, Michael J, Chou, Joanne F, Pei, Xin, Yamada, Yoshiya, Kollmeier, Marisa, Cox, Brett, Zhang, Zhigang, Schechter, Michael, Cohen, Gil’ad N, Zaider, Marco

“…Abstract Purpose To identify predictors of biochemical tumor control and present an updated prognostic nomogram for patients with clinically localized prostate…”
Get full text

Real-time intraoperative evaluation of implant quality and dose correction during prostate brachytherapy consistently improves target coverage using a novel image fusion and optimization program by Zelefsky, Michael J., Cohen, Gilad N., Taggar, Amandeep S., Kollmeier, Marisa, McBride, Sean, Mageras, Gig, Zaider, Marco

“…Our purpose was to describe the process and outcome of performing postimplantation dosimetric assessment and intraoperative dose correction during prostate…”
Get full text

A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer by Spratt, Daniel E, Scala, Lawrence M, Folkert, Michael, Voros, Laszlo, Cohen, Gil’ad N, Happersett, Laura, Katsoulakis, Evangelia, Zelefsky, Michael J, Kollmeier, Marisa A, Yamada, Yoshiya

“…Abstract Purpose Stereotactic body radiotherapy (SBRT) is being used with increasing frequency as definitive treatment of early stage prostate cancer. Much of…”
Get full text